| |
| Critical evaluation and clinical management of side effects |
|
Chair: D. Cibula (Czech Rep) K. Sedlecki (Serbia) |
| |
|
|
Mood
changes/depression, R. Van Lunsen (The Netherlands) |
|
|
Weight
changes, M. Lech (Poland) |
|
|
BMD, D. Cibula (Czech Rep.) |
|
|
Breakthrough bleeding, D. Archer (USA) |
|
|
| Screening and management of STI
in family planning |
| Chair: V. Cupanik (Slovakia) T. Bombas
(Portugal) |
| |
|
|
WHO Global STI Epidemiology Update , G. Lazdane (WHO,
Copenhagen) |
|
|
Testing for STIs in a Family Planning Setting How
to Make It Simple?, A. Bigrigg (United Kingdom) |
|
|
Guidelines for HPV
DNA Testing To Test or not to Test, Speaker TBC |
|
|
Genital
Chlamydial Infection: Has the Risk for Tubal Factor Infertility and
Adverse Pregnancy Outcome been Exaggerated? Speaker TBC |
|
|
| Intrauterine
contraception |
| Chair: G. Bartfai (Hungary) C. McNicholas (Ireland) |
| |
|
|
IUD/IUS in nulliparous women, I. Sivin (USA) |
|
|
Management in
special clinical conditions (dysplasia, postpartum insertion, HIV,
emergency contraception ...), D. Serfaty (France) |
|
|
Non-contraceptive benefits, D. Mansour (United Kingdom) |
|
|
Long-term
use/use beyond recommended time, I. Batar (Hungary) |
|
|
| Do guidelines make
any change? (WHO special session) |
| Chair: V. Cupanik (Slovakia) I.
Savelieva (Russia) |
| |
|
|
The WHO family planning cornerstones: a living
testimony to the power of partnership, P. van Look (WHO, Geneva) |
|
|
Implementation of family planning guidelines in Europe adoption
and adaptation, G. Lazdane (WHO, Copenhagen) |
|
|
Recommended changes
in practice, A. Glasier (United Kingdom) |
|
|
| Induced abortion - An update |
|
Chair: V. Prilepskaya (Russia) A. Pretnar-Darovec (Slovenia) |
| |
|
|
The challenge of post-abortion contraception, K. Gemzell (Sweden) |
|
|
Follow-up after induced abortion: current practice and evidence, C.
Fiala (Austria) |
|
|
Access to safe abortion: legal and other
obstacles, M. Vekemans (United Kingdom) |
|
|
| Contraception for medically
compromised women |
| Chair: S. Φzalp (Turkey) H. Missey-Kolb
(France) |
| |
|
|
Hormonal Contraception in women with disorders of
carbohydrate metabolism, A. Cagnacci (Italy) |
|
|
Hormonal
contraception in women with coagulation disorders and thrombophilia,
J. Connard (France) |
|
|
Hormonal Contraception in Women with Mental
Diseases, T. Backstrom (Sweden) |
|
|
Contraceptive Management of women
or couples with HIV, S. Killick (United Kingdom) |
|
|